Share this article
Share this article
ResearchAndMarkets.com s offering.
The global autoinjectors market was valued at $ 1,509.0 million in 2019 and is expected to reach $ 5,732.6 million by 2027, with a CAGR of 18.1% during the forecast period.
An autoinjector is defined as a syringe with a spring-charged needle having a pre-charged dosage of drugs. The system triggers and administers a measured dosage of a drug when pressed into the body with a slicing motion. Autoinjectors are widely used for epinephrine self-administration (to prevent anaphylaxis); by migraine sufferers (for immediate pain relief); or for medical and emergency treatments. Auto-injectors provide multiple benefits such as decreasing needle-related phobia disorder, decreasing risks of needle stuck accidents, ensuring dosage quality continuity, and helping to increase effectiveness.